Dr. Reddy’s Q2 net dips 32% to ₹913 cr on lower revenue
Dr. Reddy’s Q2 net falls 32% to ₹913 cr amid softer North America generics, declining revenue, and ongoing product relaunch plans.
BTC-1.10%
ETH-0.99%
SOL-1.77%
XRP-2.29%
USDC+0.00%
GRAMTON-6.56%
KAN-66.25%
SUI-2.56%BTC-1.10%ETH-0.99%SOL-1.77%XRP-2.29%USDC+0.00%GRAMTON-6.56%KAN-66.25%SUI-2.56%BTC-1.10%ETH-0.99%SOL-1.77%XRP-2.29%USDC+0.00%GRAMTON-6.56%KAN-66.25%SUI-2.56%BTC-1.10%ETH-0.99%SOL-1.77%XRP-2.29%USDC+0.00%GRAMTON-6.56%KAN-66.25%SUI-2.56%
